• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人、小鼠和大鼠细胞对5-氟尿嘧啶和5'-脱氧-5-氟尿苷的敏感性与药物代谢酶的关系。

Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.

作者信息

Peters G J, Laurensse E, Leyva A, Lankelma J, Pinedo H M

出版信息

Cancer Res. 1986 Jan;46(1):20-8.

PMID:2415245
Abstract

Six cell lines differing in histological origin were studied regarding the growth inhibitory effect of fluoropyrimidines in relation to their metabolism. The human colon carcinoma cell line WiDr was most sensitive to 5-fluorouracil (FUra) (50% growth inhibitory concentration, 0.7 microM) and to its analogue 5'deoxy-5-fluorouridine (5'dFUR) (50% growth inhibitory concentration, 18 microM). The murine B16 melanoma cell line was moderately sensitive to FUra but least sensitive to 5'dFUR. The 50% growth inhibitory concentration values in the human melanoma cell lines IGR3 and M5, the transformed human intestine cell line intestine 407 and the rat hepatoma cell line H35 varied for FUra between 1.7 and 5.0 microM, and for 5'dFUR between 54 and 160 microM. Several enzymes from pyrimidine metabolism responsible for FUra metabolism were measured with FUra as a substrate. The activity of uridine phosphorylase, which catalyzes the conversion of 5'dFUR to FUra, was lowest in B16 cells correlating with the low sensitivity to 5'dFUR. When adenosine 5'-triphosphate was included in the reaction mixture for uridine phosphorylase, FUra was rapidly channeled into FUra nucleotides via its nucleoside. The rate of channeling appeared to correlate with the nucleoside phosphorylase activity in the various cell lines. In several cell lines activities of nucleotide-degrading enzymes were rather high and interfered with the measurement of orotate phosphoribosyl transferase (OPRT) with FUra as substrate. Addition of the phosphatase inhibitor glycerol-2-phosphate partly prevented breakdown of the newly formed 5-fluorouridine 5'-monophosphate and enabled measurement of OPRT. The WiDr cell line had a relatively high OPRT activity which could explain its sensitivity to FUra. The activity of thymidylate synthase was measured at a suboptimal concentration of 1 microM and at the optimal concentration of 10 microM deoxyuridine 5'-phosphate. With all cell lines the ratio between the activities at 10 and 1 microM was between 2.3 and 3.6. The activity of thymidylate synthase was lowest in WiDr and IGR3 cells and 3-4 times higher in M5 and Intestine 407 cells. The inhibition of 0.01 microM 5-fluorodeoxyuridine 5'-monophosphate was 80-90% at 1 microM deoxyuridine 5'-phosphate and 50-70% at 10 microM deoxyuridine 5'-phosphate with all cell lines. At 0.1 microM 5-fluorodeoxyuridine 5'-monophosphate enzyme activity was inhibited by 95-100%. The incorporation of FUra into RNA was relatively low in IGR3 cells and 3-5 times higher in all other cell lines.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

研究了六种组织学来源不同的细胞系对氟嘧啶生长抑制作用及其代谢的关系。人结肠癌细胞系WiDr对5-氟尿嘧啶(FUra)最敏感(50%生长抑制浓度,0.7微摩尔)及其类似物5'-脱氧-5-氟尿苷(5'dFUR)(50%生长抑制浓度,18微摩尔)。小鼠B16黑色素瘤细胞系对FUra中度敏感,但对5'dFUR最不敏感。人黑色素瘤细胞系IGR3和M5、转化的人肠细胞系肠407和大鼠肝癌细胞系H35中,FUra的50%生长抑制浓度值在1.7至5.0微摩尔之间,5'dFUR在54至160微摩尔之间。以FUra为底物测定了几种嘧啶代谢中负责FUra代谢的酶。催化5'dFUR转化为FUra的尿苷磷酸化酶活性在B16细胞中最低,这与对5'dFUR的低敏感性相关。当将三磷酸腺苷加入尿苷磷酸化酶的反应混合物中时,FUra通过其核苷迅速转化为FUra核苷酸。转化速率似乎与各种细胞系中的核苷磷酸化酶活性相关。在几个细胞系中,核苷酸降解酶的活性相当高,干扰了以FUra为底物的乳清酸磷酸核糖基转移酶(OPRT)的测定。加入磷酸酶抑制剂甘油-2-磷酸部分阻止了新形成的5-氟尿苷5'-单磷酸的分解,并能够测定OPRT。WiDr细胞系具有相对较高的OPRT活性,这可以解释其对FUra的敏感性。胸苷酸合成酶的活性在1微摩尔次优浓度和10微摩尔脱氧尿苷5'-磷酸的最佳浓度下测定。在所有细胞系中,10微摩尔和1微摩尔时的活性之比在2.3至3.6之间。胸苷酸合成酶的活性在WiDr和IGR3细胞中最低,在M5和肠407细胞中高3至4倍。在所有细胞系中,0.01微摩尔5-氟脱氧尿苷5'-单磷酸在1微摩尔脱氧尿苷5'-磷酸时的抑制率为80-90%,在10微摩尔脱氧尿苷5'-磷酸时为50-70%。在0.1微摩尔5-氟脱氧尿苷5'-单磷酸时,酶活性被抑制95-100%。IGR3细胞中FUra掺入RNA的量相对较低,在所有其他细胞系中高3至5倍。(摘要截断于400字)

相似文献

1
Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.人、小鼠和大鼠细胞对5-氟尿嘧啶和5'-脱氧-5-氟尿苷的敏感性与药物代谢酶的关系。
Cancer Res. 1986 Jan;46(1):20-8.
2
Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines.嘧啶磷酸化酶的活性和底物特异性及其在结肠癌细胞系氟嘧啶敏感性中的作用
Int J Biochem Cell Biol. 2007;39(3):565-75. doi: 10.1016/j.biocel.2006.10.009. Epub 2006 Oct 21.
3
Increased cytotoxicity of 5'-deoxy-5-fluorouridine by prolonged culture with folinic acid.
Anticancer Res. 1993 Nov-Dec;13(6A):2201-6.
4
Role of uridine phosphorylase in the anabolism of 5-fluorouracil.
Biochem Pharmacol. 1985 Oct 1;34(19):3585-9. doi: 10.1016/0006-2952(85)90737-3.
5
Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines.尿苷磷酸化酶(-/-)小鼠胚胎干细胞阐明了该酶在嘧啶补救途径调节和氟嘧啶激活中的关键作用。
Cancer Res. 2002 Apr 15;62(8):2313-7.
6
Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index.肿瘤细胞对5'-脱氧-5-氟尿苷的选择性激活作为提高治疗指数的基础。
Cancer Res. 1981 Dec;41(12 Pt 1):4891-4.
7
Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.人结肠癌细胞长期暴露于氟尿嘧啶时细胞毒性的决定因素。
Oncol Res. 1997;9(2):77-88.
8
Enhancement by uridine of the anabolism of 5-fluorouracil in mouse T-lymphoma (S-49) cells.尿苷对小鼠T淋巴瘤(S-49)细胞中5-氟尿嘧啶合成代谢的增强作用。
Cancer Res. 1985 Sep;45(9):4249-56.
9
[Activities of enzymes converting 5-fluorouracil to 5-fluorouridine-5' monophosphate and 5-fluorodeoxyuridine-5' monophosphate in subcultured cell lines and solid tumor tissues].[传代细胞系和实体瘤组织中5-氟尿嘧啶转化为5-氟尿苷-5'-单磷酸和5-氟脱氧尿苷-5'-单磷酸的酶活性]
Nihon Gan Chiryo Gakkai Shi. 1990 May 20;25(5):990-6.
10
Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules.在暴露于两种不同的临床相关剂量方案后,人结肠癌(HCT-8)亚系对5-氟尿嘧啶产生耐药性的新机制。
Cancer Res. 1992 Apr 1;52(7):1855-64.

引用本文的文献

1
Association of the expression of 5-FU biomarkers with aging and prognosis in elderly patients with lung cancer treated with S-1 adjuvant chemotherapy: Follow-up results of the Setouchi Lung Cancer Group Study 1201.5-氟尿嘧啶生物标志物表达与接受S-1辅助化疗的老年肺癌患者衰老及预后的相关性:濑户内肺癌研究组1201研究的随访结果
Mol Clin Oncol. 2025 Jul 3;23(3):79. doi: 10.3892/mco.2025.2874. eCollection 2025 Sep.
2
Uridine-sensitized screening identifies genes and metabolic regulators of nucleotide synthesis.尿苷敏化筛选可鉴定核苷酸合成的基因和代谢调节因子。
bioRxiv. 2025 Mar 13:2025.03.11.642569. doi: 10.1101/2025.03.11.642569.
3
A novel view on an old drug, 5-fluorouracil: an unexpected RNA modifier with intriguing impact on cancer cell fate.
对一种老药5-氟尿嘧啶的全新见解:一种意想不到的RNA修饰剂,对癌细胞命运有着引人入胜的影响。
NAR Cancer. 2021 Aug 14;3(3):zcab032. doi: 10.1093/narcan/zcab032. eCollection 2021 Sep.
4
Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method.基于液相色谱-高分辨质谱法的5-氟尿嘧啶细胞内合成代谢及其掺入核酸的研究
J Pharm Anal. 2021 Feb;11(1):77-87. doi: 10.1016/j.jpha.2020.04.001. Epub 2020 Apr 7.
5
Intracellular Pharmacokinetics of Pyrimidine Analogues used in Oncology and the Correlation with Drug Action.肿瘤治疗中嘧啶类似物的细胞内药代动力学及其与药物作用的相关性。
Clin Pharmacokinet. 2020 Dec;59(12):1521-1550. doi: 10.1007/s40262-020-00934-7.
6
Study of Thymidylate Synthase (TS) and Dihydropyrimidine Dehydrogenase (DPD) Expressions on 5-Fluorouracil in Oral Squamous Cell Carcinoma.口腔鳞状细胞癌中胸苷酸合成酶(TS)和二氢嘧啶脱氢酶(DPD)表达对5-氟尿嘧啶影响的研究。
Asian Pac J Cancer Prev. 2019 Feb 26;20(2):503-508. doi: 10.31557/APJCP.2019.20.2.503.
7
5FU resistance caused by reduced fluoro-deoxyuridine monophosphate and its reversal using deoxyuridine.氟代脱氧尿苷单磷酸减少导致的5-氟尿嘧啶耐药性及其通过脱氧尿苷的逆转
Oncol Lett. 2017 Sep;14(3):3162-3168. doi: 10.3892/ol.2017.6512. Epub 2017 Jun 30.
8
DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy.水仙:一种新型脂质体包裹的阿霉素与5-氟尿嘧啶协同组合用于低剂量化疗。
J Control Release. 2016 May 10;229:154-162. doi: 10.1016/j.jconrel.2016.03.027. Epub 2016 Mar 24.
9
Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma.S-1治疗难治性胸腺癌的疗效与生物标志物表达之间的相关性
BMC Cancer. 2016 Feb 25;16:156. doi: 10.1186/s12885-016-2159-7.
10
Exploring the intracellular pharmacokinetics of the 5-fluorouracil nucleotides during capecitabine treatment.探索卡培他滨治疗期间5-氟尿嘧啶核苷酸的细胞内药代动力学。
Br J Clin Pharmacol. 2016 May;81(5):949-57. doi: 10.1111/bcp.12877. Epub 2016 Mar 2.